Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | TNBC: the targeted therapy era

Adam Brufsky, MD, PhD, of the University of Pittsburgh Medical Center. Pittsburgh, PA, tells us about the progress we are seeing in the triple-negative breast cancer (TNBC) field with the rise of targeted agents. Speaking at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Dr Brufsky goes on to discuss upcoming trials in the field that he is excited for.